Cited by

• Protein-templated ligand discovery via the selection of DNA-encoded dynamic libraries.

  Zhou Y, Shen W, Gao Y, Peng J, Li Q, Wei X, Liu S, Lam FS, Mayol-Llinàs J, Zhao G, Li G, Li Y, Sun H, Cao Y, Li X. Zhou Y, et al. Nat Chem. 2024 Apr;16(4):543-555. doi: 10.1038/s41557-024-01442-y. Epub 2024 Feb 7. Nat Chem. 2024. PMID: 38326646
• Advancing T cell-based cancer therapy with single-cell technologies.

  Bucktrout SL, Banovich NE, Butterfield LH, Cimen-Bozkus C, Giles JR, Good Z, Goodman D, Jonsson VD, Lareau C, Marson A, Maurer DM, Munson PV, Stubbington M, Taylor S, Cutchin A. Bucktrout SL, et al. Nat Med. 2022 Sep;28(9):1761-1764. doi: 10.1038/s41591-022-01986-x. Nat Med. 2022. PMID: 36127419 No abstract available.
• Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.

  Nguyen TT, Katt WP, Cerione RA. Nguyen TT, et al. Future Drug Discov. 2023 Mar;4(4):FDD79. doi: 10.4155/fdd-2022-0011. Epub 2023 Mar 27. Future Drug Discov. 2023. PMID: 37009252 Free PMC article. Review.
• Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure.

  Gergely TG, Drobni ZD, Kallikourdis M, Zhu H, Meijers WC, Neilan TG, Rassaf T, Ferdinandy P, Varga ZV. Gergely TG, et al. Nat Rev Cardiol. 2024 Jul;21(7):443-462. doi: 10.1038/s41569-023-00986-9. Epub 2024 Jan 26. Nat Rev Cardiol. 2024. PMID: 38279046 Review.
• Silencing NEDD4L Effectively Inhibits the Malignant Behaviors of Hepatocellular Carcinoma.

  Dai J, Zhu T, Wan J, Liu R, Song Y, Zhang D, Wang X, Zhang H, Li W, Lin J, Zhu X, Liu Y. Dai J, et al. J Hepatocell Carcinoma. 2025 Jul 10;12:1369-1391. doi: 10.2147/JHC.S511466. eCollection 2025. J Hepatocell Carcinoma. 2025. PMID: 40661237 Free PMC article.